Gene · 6579
Papers2,617
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
401 to 420 of 2,617
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Oral Pharmacokinetics of Hydroxycinnamic Acids: An Updated Review. | Pharmaceutics | 2022 | 36559157 | PubTator, text mining | PubMed |
| Post-Marketing Surveillance of Statins-A Descriptive Analysis of Psychiatric Adverse Reactions in EudraVigilance. | Pharmaceuticals (Basel) | 2022 | 36558987 | PubTator, text mining | PubMed |
| Genome-Scale Metabolic Modeling Reveals Sequential Dysregulation of Glutathione Metabolism in Livers from Patients with Alcoholic Hepatitis. | Metabolites | 2022 | 36557195 | PubTator, text mining | PubMed |
| Metabolic Effect of Blocking Sodium-Taurocholate Co-Transporting Polypeptide in Hypercholesterolemic Humans with a Twelve-Week Course of Bulevirtide-An Exploratory Phase I Clinical Trial. | Int J Mol Sci | 2022 | 36555566 | PubTator, text mining | PubMed |
| Human Breast Milk Contamination with Aflatoxins, Impact on Children's Health, and Possible Control Means: A Review. | Int J Environ Res Public Health | 2022 | 36554670 | PubTator, text mining | PubMed |
| Hepatic Polarized Differentiation Promoted the Maturity and Liver Function of Human Embryonic Stem Cell-Derived Hepatocytes via Activating Hippo and AMPK Signaling Pathways. | Cells | 2022 | 36552880 | PubTator, text mining | PubMed |
| Multiparametric MRI combined with liver volume for quantitative evaluation of liver function in patients with cirrhosis. | Diagn Interv Radiol | 2022 | 36550754 | PubTator, text mining | PubMed |
| Applications of In Silico Models to Predict Drug-Induced Liver Injury. | Toxics | 2022 | 36548621 | PubTator, text mining | PubMed |
| Delivery of Drugs into Cancer Cells Using Antibody-Drug Conjugates Based on Receptor-Mediated Endocytosis and the Enhanced Permeability and Retention Effect. | Antibodies (Basel) | 2022 | 36546903 | PubTator, text mining | PubMed |
| Association between high-dose methotrexate-induced toxicity and polymorphisms within methotrexate pathway genes in acute lymphoblastic leukemia. | Front Pharmacol | 2022 | 36532750 | PubTator, text mining | PubMed |
| Role of bile acids in overweight and obese children and adolescents. | Front Endocrinol (Lausanne) | 2022 | 36531484 | PubTator, text mining | PubMed |
| Drug-induced liver injury in COVID-19 treatment: Incidence, mechanisms and clinical management. | Front Pharmacol | 2022 | 36518661 | PubTator, text mining | PubMed |
| Recent Advances in the Digestive, Metabolic and Therapeutic Effects of Farnesoid X Receptor and Fibroblast Growth Factor 19: From Cholesterol to Bile Acid Signaling. | Nutrients | 2022 | 36500979 | PubTator, text mining | PubMed |
| Comparative Modelling of Organic Anion Transporting Polypeptides: Structural Insights and Comparison of Binding Modes. | Molecules | 2022 | 36500622 | PubTator, text mining | PubMed |
| Thyroid Hormone Transporters in Pregnancy and Fetal Development. | Int J Mol Sci | 2022 | 36499435 | PubTator, text mining | PubMed |
| Drug-Drug Interactions among Patients Hospitalized with COVID-19 in Greece. | J Clin Med | 2022 | 36498745 | PubTator, text mining | PubMed |
| Liver-derived metabolites as signaling molecules in fatty liver disease. | Cell Mol Life Sci | 2022 | 36477411 | PubTator, text mining | PubMed |
| Potential value of the homologous recombination deficiency signature we developed in the prognosis and drug sensitivity of gastric cancer. | Front Genet | 2022 | 36468004 | PubTator, text mining | PubMed |
| Treatment of Nonalcoholic Steatohepatitis by Obeticholic Acid: Current Status. | Euroasian J Hepatogastroenterol | 2022 | 36466097 | PubTator, text mining | PubMed |
| Imaging features of β-catenin-activated hepatocellular adenoma with weak β-catenin activation: A rare case report. | Acta Radiol Open | 2022 | 36439281 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6579/papers?page=21